Ophthalmology · Dorado, PR
NPI
1699183376
Since 2014
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
257 Calle Mendez Vigo
Dorado, PR, 00646
Phone (787) 278-0830
Groups this clinician bills Medicare through
Medicare paid, 2024
$20K
264 services
Medicare patients, 2024
60
Average age 78
Drug cost, 2024
$958K
9,673 prescriptions
Company payments, 2025
$500
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Esteban M Vazquez-Valencia was code 92012 (ophthalmological e&m), 85 times for 33 patients. In total Esteban M Vazquez-Valencia billed 264 services in 22 codes, and Medicare paid $20K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92012 Ophthalmological E&M | Office | 85 | 33 | $55.17 | $4,689 |
| 92201 Ophthalmological E&M | Office | 31 | 28 | $14.20 | $440 |
| 92014 Ophthalmological E&M | Office | 27 | 24 | $77.92 | $2,104 |
| 92133 Computerized Ophthalmic Imaging | Office | 23 | 19 | $19.44 | $447 |
| 92250 Angiography | Office | 14 | 14 | $28.47 | $399 |
| 92004 Ophthalmological E&M | Office | 13 | 13 | $90.69 | $1,179 |
By year: 2022 $15K for 228 services; 2023 $22K for 294 services; 2024 $20K for 264 services.
Medicare prescription drug claims, 2024
In 2024, the drug Esteban M Vazquez-Valencia prescribed most often to Medicare patients was Latanoprost, with 2,349 prescriptions and refills. In total Esteban M Vazquez-Valencia wrote 9,673 Medicare prescriptions that cost $958K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 2,349 | 2,719 | 383 | $29K |
| Lumigan Bimatoprost | 1,409 | 1,571 | 248 | $376K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 975 | 1,721 | 232 | $32K |
| Brimonidine Tartrate Generic | 760 | 872 | 148 | $42K |
| Prednisolone Acetate Generic | 608 | 674 | 337 | $23K |
| Timolol Maleate Generic | 427 | 530 | 80 | $5,918 |
| Fluorometholone Generic | 424 | 518 | 143 | $28K |
| Ofloxacin Generic | 326 | 332 | 240 | $7,475 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 275 | 332 | 50 | $48K |
| Ketorolac Tromethamine Generic | 273 | 282 | 193 | $5,938 |
| Dorzolamide Hcl Generic | 265 | 485 | 69 | $7,977 |
| Alphagan P Brimonidine Tartrate | 245 | 259 | 57 | $53K |
| Vyzulta Latanoprostene Bunod | 164 | 184 | 38 | $43K |
| Combigan Brimonidine Tartrate/Timolol | 162 | 177 | 31 | $36K |
| Simbrinza Brinzolamide/Brimonidine Tart | 135 | 168 | 28 | $28K |
Brand drugs: 4,218 claims; generic drugs: 5,455 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Esteban M Vazquez-Valencia $500 ($500 in general payments such as food, travel and fees) from 5 companies. The largest payer was Alcon Puerto Rico Inc with $163.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.